0.0132
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Low
0.006
High
0.0499
Best deals to access real time data! |
|
Small Cap Basic
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immune Therapeutics Inc (PK) | IMUN | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.0132 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0132 | 0.0132 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.0085 | 0.0132 | 0.0047 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.0132 | USD |
Immune Therapeutics (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 6.37k | 482.35k | 7.99M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 39.99k | $ - | - | - | - |
Immune Therapeutics (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMUN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.0139 | 0.018 | 0.012 | 0.0148361 | 1,123,440 | -0.0007 | -5.04% |
| 3 Months | 0.0286 | 0.0327 | 0.006 | 0.0192129 | 1,421,344 | -0.0154 | -53.85% |
| 6 Months | 0.0158 | 0.0327 | 0.006 | 0.0185305 | 1,625,956 | -0.0026 | -16.46% |
| 1 Year | 0.016675 | 0.0499 | 0.006 | 0.023293 | 2,038,700 | -0.00348 | -20.84% |
| 3 Years | 0.0186 | 0.0499 | 0.0027 | 0.0175167 | 1,248,747 | -0.0054 | -29.03% |
| 5 Years | 0.1489 | 0.186 | 0.0027 | 0.0255257 | 1,032,557 | -0.1357 | -91.13% |
Immune Therapeutics (PK) Description
| Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies-Low-Dose Naltrexone (LDN) and Methionine Enkephalin (MENK)-which work by triggering opioid receptors on immune cells to activate various cells of the immune system. |
